Anika Therapeutics (ANIK) Other Operating Expenses (2010 - 2021)
Anika Therapeutics (ANIK) posted quarterly Other Operating Expenses of $825000.0 for Q4 2021, down 93.06% year-over-year from $11.9 million in Q4 2020, and up 123.91% quarter-over-quarter from -$3.4 million in Q3 2021.
Anika Therapeutics (ANIK) Other Operating Expenses (2010 - 2021) Analysis & Trends
Anika Therapeutics (ANIK) has reported Other Operating Expenses for 12 consecutive years, with $825000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Other Operating Expenses fell 93.06% year-over-year to $825000.0; the TTM figure through Sep 2022 stood at $825000.0 (up 108.22% YoY), while the FY2021 annual figure was -$21.1 million, down 252.27% from the prior year.
- Other Operating Expenses climbed to $825000.0 in Q4 2021 per ANIK's latest filing, from -$3.4 million in the prior quarter.
- Across five years, Other Operating Expenses topped out at $11.9 million in Q4 2020 and bottomed at -$24.3 million in Q4 2018.
- Historically, Other Operating Expenses has averaged $1.0 million across 5 years, with a median of $6.0 million in 2017.
- Annual changes were most pronounced in 2020 — Other Operating Expenses soared 159.14% — and 2021, when it plunged 425.31%.
- Anika Therapeutics' Other Operating Expenses stood at $8.7 million in 2017, then sank by 378.56% to -$24.3 million in 2018, then grew by 17.22% to -$20.1 million in 2019, then jumped by 159.14% to $11.9 million in 2020, then slumped by 93.06% to $825000.0 in 2021.
- Business Quant data shows ANIK's Other Operating Expenses at $825000.0 in Q4 2021, -$3.4 million in Q3 2021, and -$13.6 million in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Anika Therapeutics | 285.86 Mn | 247.45 Mn | 21.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 825,000.00 |
| Sep 30, 2021 | -3.45 Mn |
| Jun 30, 2021 | -13.65 Mn |
| Mar 31, 2021 | -4.82 Mn |
| Dec 31, 2020 | 11.89 Mn |
| Sep 30, 2020 | 4.15 Mn |
| Jun 30, 2020 | 4.20 Mn |
| Mar 31, 2020 | -6.38 Mn |
| Dec 31, 2019 | -20.10 Mn |
| Sep 30, 2019 | 5.95 Mn |
| Jun 30, 2019 | 6.84 Mn |
| Mar 31, 2019 | 7.31 Mn |
| Dec 31, 2018 | -24.28 Mn |
| Sep 30, 2018 | 8.28 Mn |
| Jun 30, 2018 | 8.15 Mn |
| Mar 31, 2018 | 7.85 Mn |
| Dec 31, 2017 | 8.72 Mn |
| Sep 30, 2017 | 6.25 Mn |
| Jun 30, 2017 | 6.32 Mn |
| Mar 31, 2017 | 6.08 Mn |